In vitro activity of sulbactam/durlobactam against clinical isolates of Acinetobacter baumannii collected in China
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
In vitro activity of sulbactam/durlobactam against clinical isolates of Acinetobacter baumannii collected in China
Authors
Keywords
-
Journal
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
Volume -, Issue -, Pages -
Publisher
Oxford University Press (OUP)
Online
2020-03-10
DOI
10.1093/jac/dkaa119
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Targeting Multidrug-Resistant Acinetobacter spp.: Sulbactam and the Diazabicyclooctenone β-Lactamase Inhibitor ETX2514 as a Novel Therapeutic Agent
- (2019) Melissa D. Barnes et al. mBio
- Molecular Epidemiology and Mechanism of Sulbactam Resistance in Acinetobacter baumannii Isolates with Diverse Genetic Backgrounds in China
- (2018) Yunxing Yang et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- OUP accepted manuscript
- (2018) CLINICAL INFECTIOUS DISEASES
- The difference in medical costs between carbapenem-resistant Acinetobacter baumannii and non-resistant groups: a case study from a hospital in Zhejiang province, China
- (2017) X. Zhen et al. EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES
- Reversibility of Covalent, Broad-Spectrum Serine β-Lactamase Inhibition by the Diazabicyclooctenone ETX2514
- (2017) Adam B. Shapiro et al. ACS Infectious Diseases
- ETX2514 is a broad-spectrum β-lactamase inhibitor for the treatment of drug-resistant Gram-negative bacteria including Acinetobacter baumannii
- (2017) Thomas F. Durand-Réville et al. Nature Microbiology
- Clinical and Pathophysiological Overview of Acinetobacter Infections: a Century of Challenges
- (2016) Darren Wong et al. CLINICAL MICROBIOLOGY REVIEWS
- Molecular Epidemiology and Characterization of Genotypes of Acinetobacter baumannii Isolates from Regions of South China
- (2016) Jun Ying et al. JAPANESE JOURNAL OF INFECTIOUS DISEASES
- Contribution of Acinetobacter-derived cephalosporinase-30 to sulbactam resistance in Acinetobacter baumannii
- (2015) Shu-Chen Kuo et al. Frontiers in Microbiology
- A 2015 Update on Ventilator-Associated Pneumonia: New Insights on Its Prevention, Diagnosis, and Treatment
- (2015) Braden Waters et al. Current Infectious Disease Reports
- OXA -Lactamases
- (2014) B. A. Evans et al. CLINICAL MICROBIOLOGY REVIEWS
- Ampicillin/sulbactam: Its potential use in treating infections in critically ill patients
- (2013) Syamhanin Adnan et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- The value of single-pathogen antibacterial agents
- (2013) Brad Spellberg et al. NATURE REVIEWS DRUG DISCOVERY
- Acinetobacter baumannii
- (2012) Aoife Howard et al. Virulence
- Genomic Analysis of the Multidrug-Resistant Acinetobacter baumannii Strain MDR-ZJ06 Widely Spread in China
- (2011) Hua Zhou et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Combat-related L3 fracture treated with L2–L4 posterior spinal fusion complicated by multidrug-resistant acinetobacter infection
- (2011) Theodora C. Dworak et al. Spine Journal
- Therapeutic options forAcinetobacter baumanniiinfections
- (2008) Jordi Vila et al. EXPERT OPINION ON PHARMACOTHERAPY
- Ampicillin/sulbactam compared with polymyxins for the treatment of infections caused by carbapenem-resistant Acinetobacter spp.
- (2008) M. S. Oliveira et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started